Abstract This 2022 European Atherosclerosis Society lipoprotein (a)[Lp (a)] consensus
statement updates evidence for the role of Lp (a) in atherosclerotic cardiovascular disease …

Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …

Lipoprotein (a)[Lp (a)] is a molecule bound to apolipoprotein (a) with some similarity to low-
density lipoprotein cholesterol (LDL-C), which has been found to be a risk factor for …

Background. Obesity, especially severe obesity, is associated with a higher risk of
atherosclerotic cardiovascular disease (ASCVD) morbidity and mortality. Bariatric surgery is …

Extensive research has demonstrated the efficacy of the LCD to improve the most robust
CVD risk factors, such as hyperglycemia, hypertension, and atherogenic dyslipidemia. Our …

Background and aims Lipoprotein (a)[Lp (a)] and interleuking-6 (IL-6), an inflammation
biomarker, have been established as distinct targets of the residual atherosclerotic …

The pathophysiological mechanisms underlying Myocardial Infarction with Non-Obstructive
Coronary Artery Disease (MINOCA) are still under debate. Lipoprotein (a)[Lp (a)] has …

Abstract Lipoprotein (a)[Lp (a)] is a risk factor for cardiovascular disease (CVD) and aortic
stenosis. However, the data on the relationship between Lp (a) and mildly reduced …

Abstract Background Homozygous familial hypercholesterolemia (HoFH) is an orphan
metabolic disease characterized by extremely elevated low-density lipoprotein cholesterol …

Recently, a growing body of evidence has highlighted a concerning link between
endometriosis and cardiovascular disease. Endometriosis, a chronic, inflammatory …